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Abstract
Tricho-dento-osseous syndrome (TDO). is
characterised by a variable clinical phe-
notype primarily affecting the hair, teeth,
and bone. Different clinical features are
observed between and within TDO fami-
lies. It is not known whether the variable
clinical features are the result of genetic
heterogeneity or clinical variability. A
gene for TDO was localised recently to
chromosome 17q21 in four North Carolina
families, and a 4 bp deletion in the human
distal-less 3 gene (DLX3) was identified in
all affected members. A previous genetic
linkage study in a large Virginia kindred
with TDO indicated possible linkage to the
ABO, Gc, and Kell blood group loci. To
examine whether TDO exhibits genetic
heterogeneity, we have performed mo-
lecular genetic analysis to determine
whether affected members ofthis Virginia
kindred have the DLX3 gene deletion
identified in North Carolina families.
Results show that affected subjects (n=3)
from the Virginia family have the same
four nucleotide deletion previously identi-
fied in the North Carolina families. A
common haplotype for three genetic
markers surrounding the DLX3 gene was
identified in all affected subjects in the
North Carolina and Virginia families.
These findings suggest that all people with
TDO who have been evaluated have inher-
ited the same DLX3 gene deletion muta-
tion from a common ancestor. The
variable clinical phenotype observed in
these North Carolina and Virginia fami-
lies, which share a common gene muta-
tion, suggests that clinical variability is
not the result of genetic heterogeneity at
the major locus, but may reflect genetic
heterogeneity at other epigenetic loci or
contributing environmental factors or
both.
(7Med Genet 1998;35:825-828)
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Tricho-dento-osseous syndrome (TDO) is a
highly penetrant, autosomal dominant trait
characterised by abnormalities of the hair,
teeth, and bone. The phenotypic features
include kinky/curly hair at birth, enamel hypo-
plasia, taurodontism (enlarged pulp cham-
bers), and thickening or increased density of
the cortical bones of the skull.' Other pheno-
typic features reported to be associated with
TDO include flat fingernails and altered
craniofacial morphology, including macro-
cephaly and dolichocephaly.3 The reported
diversity of the TDO phenotype and the
apparent segregation of specific clinical traits
within some families resulted in classification
of TDO into three subtypes.4 It is not known
whether these different TDO clinical subtypes
result from genetic heterogeneity involving
non-allelic mutations, allelic mutations, or
variable expression of a single gene mutation.
Recently, genetic linkage was identified on
chromosome 17q21 for TDO in four North
Carolina families.5 Subsequent haplotype
analysis and mutational studies showed that all
affected subjects (n=46) in these four families
and the affected subjects from two additional
small North Carolina families (n=7) shared a
common haplotype for three polymorphic
markers flanking the DLX3 gene.6 A 4 bp dele-
tion in the DLX3 gene (GenBank AF028233)
was subsequently identified in all affected
members of the six families.6 The common
haplotype and gene mutation suggest that
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Figure 1 Pedigree showing subjects examined and studied in the current report and their relationship to the original
Virginia kindred reported by Lichtenstein and Warson.' Subjects with TDO are shaded. Numbered subjects were examined
in the present study.
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Figure 2 A marked increase in bone density and thickness
is seen in this adult emale with TDO (pedigree Vli).
TDO in these six families was inherited from a
common ancestor.
The observation of a common gene muta-
tion in the North Carolina families suggests
that variable expression of a single gene muta-
tion is responsible for the differences in clinical
characteristics observed between and within
these six families. To date, the only other
genetic linkage study for TDO was performed
by Rivas et ar in a large Virginia kindred.
Results of this linkage analysis using polymor-
phic protein markers suggested possible link-
age with the ABO, Gc, and Kell blood group
loci (for the ABO locus, Zmax=0.70, 0=0.00).
However, recent evaluation of genetic poly-
morphisms located near these loci excluded
linkage of TDO in four large North Carolina
families (all lod scores <-2.0).8 These results
argue against a TDO gene modifying gene(s)
genetically linked to the ABO, Gc, or Kell loci.
The purpose of this study was to evaluate
affected and unaffected subjects from the large
Virginia family originally reported by Lichten-
stein and Warson' to determine whether the
genetic basis for TDO in this kindred is the




We have identified, clinically examined, and
sampled six subjects related to the TDO
kindred of 169 people originally reported by
Lichtenstein and Warson' (fig 1). Three of
these subjects were examined clinically and
radiographically as previously described.8
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Figure 3 Taurodontism of the posterior teeth and enlarged pulp chambers of the anterior
teeth are evident in this 15 year old male with TDO (pedigree VI. 1).
MOLECULAR GENETIC ANALYSIS
DNA was isolated from buccal swabs as previ-
ously described.8 The six family members were
genotyped for three highly polymorphic ge-
netic markers flanking the DLX3 gene
(D 17S941, DLX3, and D17S943) by standard
methods.5 6 To test for the presence of the
DLX3 deletion found in the six North
Carolina TDO families, the six Virginia family
members were analysed for the DLX3 exon 3
deletion using PCR amplification.6 Briefly,
primers flanking the 4 bp DLX3 gene deletion
were used to PCR amplify genomic DNA. The
normal allele results in a 145 bp product and
the deleted allele results in a 141 bp product.
The PCR products of each subject were
subcloned into pGEM-T Easy (Promega,
Madison, WI) and six individual clones were
sequenced by the Wake Forest University
Medical Center Sequencing Core facility using
a Prism 377 automated sequencer (Applied
Biosystems, Foster City, CA).
Results
CLINICAL FINDINGS
The six family members studied are shown in
relation to the kindred reported by Lichten-
stein et at (fig 1). All affected subjects were
reported to have kinky/curly hair in infant pho-
tographs, while none of the unaffected subjects
had kinky or curly hair. The affected woman
(V.11) and her affected son (VI.I) both showed
marked osseous changes radiographically com-
pared with the unaffected father. Affected sub-
jects also exhibited obliteration of diploe and a
complete lack of visible mastoid pneumatisa-
tion. Although these osseous changes were evi-
dent in the 15 year old proband, they were
much more pronounced in his mother (fig 2).
The proband had teeth with small clinical
crowns and thin enamel. Radiographically,
taurodontism was present in all the molars (fig
3). His affected mother was edentulous, and his
unaffected father had normal dentition. Teeth
are missing in affected subjects secondary to
dental abscess formation treated by extraction
and not to developmental hypodontia.
MOLECULAR FINDINGS
All three affected subjects carried the same
haplotype for the three polymorphic markers
(D17S941, DLX3, D17S941) flanking the
DLX3 locus that have been identified as com-
mon to all TDO affected subjects (n=46) from
the North Carolina families.6
PCR deletion analysis showed that the three
affected subjects studied have the normal 145
bp allele and the deleted 141 bp allele (fig 4A).
The three unaffected subjects only exhibited
the normal 145 bp allele. The PCR products
from an affected subject were subcloned and
six individual clones were sequenced, clearly
showing the 4 bp deletion.
The 4 bp deletion results in a frameshift of
the 3' terminal portion of DLX3 (fig 4B), but
leaves the homeodomain intact. A premature
termination codon is present in the deletion
allele, resulting in a mutant protein which is 32
amino acids shorter that the wild type DLX3
protein. The 4 bp deletion was observed in only
lPrice, Wright, Kula, et al
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... K L Y K N G E V P L E H S ...
Deleted allele
...AAGAAACTCTACAAGAACAGGTGCCGCTGGAGCACAGTCCCA...
...K K L Y K N R C R W S T V P
Figure 4 Deletion analysis of six members of the Virginia kindred. (A) PCR deletion
analysis of the Virginia pedigree. Pedigree numbers correlate to those in fig 1. The three
affected subjects exhibit the normal 145 bp allele and the 141 bp deleted allele. Unaffected
subjects only exhibit the normal allele. (B) Partial nucleotide and amino acid sequence
(exon 3) of the normal and deleted allele. The 4 bp deletion is indicated by an overhead
triangle. The 3' end of the homeodomain is underlined.
* Washington Co, VA (Lichtenstein and Warson1)
El Holsten Valley TN (Quattromani et al2)
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Figure 5 Map showing geographical distribution of TDO kindreds identified in the south
eastern USA.
one copy of the DLX3 gene which is consistent
with TDO being transmitted as an autosomal
dominant trait. Only the undeleted 145 bp
allele was observed in the three unaffected
family members.
Discussion
The present study shows that a common
mutation is present in affected TDO subjects
from the six North Carolina families previously
reported by Price et at and the large Virginia
kindred previously reported by Lichtenstein et
al.9 Additionally, the affected subjects from this
Virginia kindred have the same haplotype
region found in all those with TDO who have
been tested to date. This finding suggests all
affected subjects from these families inherited
the mutant DLX3 allele from a common
ancestor.
To date there have been four large popula-
tions in the United States identified with TDO.
Three of these populations are located in geo-
graphical proximity to each other (fig 5). The
kindred reported by Melnick et al'° is derived
from one of the North Carolina kindreds.8 The
results of the present study suggest that the
concentration of people with TDO in this geo-
graphical region results from a founder effect
and that these kindreds share a common
ancestry.
Phenotypic diversity that appeared to show
familial segregation resulted in the suggestion
that TDO has three subtypes.4 Careful charac-
terisation of the clinical phenotype in the
North Carolina families documents variable
expression of TDO even within nuclear
families.8 Shapiro et al4 suggested that the kin-
dred reported by Lichtenstein et al9 can be
classified as TDO type I based primarily on a
lack of calvarial changes seen in the proposed
TDO types II and III. While Lichtenstein and
Warson' did report increased bone density,
they did not describe an increased thickness of
the calvaria or obliteration of diploe. In the
North Carolina families increased thickness of
the calvarial bone and obliteration of diploe
were seen in 65% and 68% of affected subjects,
respectively. In the original reports by Lichten-
stein and Warson' and Lichtenstein et al,9 only
10 affected subjects were examined radio-
graphically with half of those examined being
below the age of 18 years. It is possible with this
limited sample and the variable expression of
bone changes in TDO families that these
changes were present but not observed. The
present study clearly shows that members of
the Virginia kindred can have increased bone
density as has been described for TDO types II
and III.
Dysplastic dentin was reported as a unique
feature for TDO type II.4 Studies of teeth from
the North Carolina families showed that
approximately 64% had irregular dentin seen
primarily in the region coronal to the pulp."
Thus, dentinal changes appear to be variably
expressed in subjects with TDO. It is not
known whether dentinal changes seen in
affected teeth result from expression of the
mutant DLX3 gene or occur secondary to thin
enamel and excess attrition. The variability of
TDO phenotypes in these families having the
same DLX3 gene mutation and sharing a com-
mon haplotype for genetic STRP loci sur-
rounding the DLX3 gene argue against the
existence of multiple TDO subtypes based on
phenotypic variation.
In summary, it appears that the TDO
syndrome segregating in these North Carolina
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affected subjects share the same DLX3 gene
deletion mutation and appear to have inherited
the gene "identical by descent" from a
common ancestor. The variable clinical pheno-
type found in these North Carolina and
Virginia families suggests that clinical variabil-
ity is not the result of genetic heterogeneity at
the major locus, but may reflect genetic
heterogeneity at other epigenetic loci or
contributing environmental factors. It is un-
likely that modifier genes exist close to the
ABO, Gc, or Kell loci, as linkage for TDO to
genetic markers in these regions was excluded
for the North Carolina families. Subclassifica-
tion of the TDO syndrome based upon
reported clinical phenotypes does not appear
consistent with the genetic aetiology of the
condition in these families.
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